Antiherpes peptide derivatives having a 1,4-dioxo-C, N-terminus

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

514 17, 514 19, 530331, 562561, 562571, A61K 3806

Patent

active

054847710

ABSTRACT:
Described herein are peptide derivatives of the formula R.sup.1 NH--CO--Q--C(O)--NR.sup.2 --CH[CH.sub.2 C(O)--Y]--C(O)--NH--CH[CR.sup.3 (R.sup.4)--COOH]--C(W)--NH--CHR.sup.5 --Z wherein R.sup.1 is an optionally substituted alkyl or optionally substituted phenylalkyl, R.sup.2 is hydrogen or alkyl, R.sup.3 and R.sup.4 each independently is hydrogen or alkyl, or R.sup.3 and R.sup.4 are joined to form a cycloalkyl. R.sup.5 is alkyl, cycloalkyl or (cycloalkyl)alkyl, Q is a divalent radical, for example, --CH.sub.2 CH.sub.2 --, --CH.dbd.CH-- or 1,2-cyclohexanediyl, which serves as a two carbon spacer. W is oxo or thioxo, Y is, for example, an alkoxy or a monosubstituted or disubsdtuted ammo, and Z is a terminal unit, for example, hydrogen, COOH or CH.sub.2 OH. The derivatives are useful for treating herpes infections.

REFERENCES:
Gaudreau J Biol Chem 262, 12413, 1987.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Antiherpes peptide derivatives having a 1,4-dioxo-C, N-terminus does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Antiherpes peptide derivatives having a 1,4-dioxo-C, N-terminus, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antiherpes peptide derivatives having a 1,4-dioxo-C, N-terminus will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-309380

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.